SCHEMBL15918525

SCHEMBL15918525

CC(=O)NCc1ccc(O[C@@H]2CCNC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ACACB O00763 2/20 0.49
HTR2C P28335 1/20 0.49
HRH1 P35367 1/20 0.45
F10 P00742 6/20 0.44
F2 P00734 3/20 0.44
MMP2 P08253 1/20 0.44
MMP8 P22894 1/20 0.44
S1PR3 Q99500 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19724972 0.84 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2ACACBHTR2CHRH1
SCHEMBL12001266 0.78 ACACB (0.52) ALDH1A1ACACBMMP2MMP8KMT2A
SCHEMBL13766409 0.77 HRH1 (0.54) HTR2CHRH1F10F2
SCHEMBL19724789 0.77 HRH1 (0.62) ALDH1A1HTR2CHRH1CTSLCTSB
SCHEMBL14578145 0.77 HRH1 (0.71) HTR2CHRH1F10F2
SCHEMBL5098947 0.76 CHRM3 (0.50) ALDH1A1SMN1; SMN2HTR2CHRH1CTSL
SCHEMBL8893118 0.75 F10 (0.52) HRH1F10F2KMT2A
SCHEMBL15918526 0.75 ACACB (0.64) ACACB
SCHEMBL19724701 0.75 ACACB (0.48) ACACBHTR2CF10F2
SCHEMBL16187534 0.75 ACACB (0.64) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2986604-B1 PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2017-12-20 EP disclosed
WO-2014114578-A1 PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-31 WO disclosed